Ep 26: Builders Win: Interstate Cannabis Commerce: Who Wins When Markets Open? — The Shift

with Filip Gacic · The Shift, a podcast by Headquarters

Who wins when cannabis crosses state lines? Explore how interstate commerce could reshape competition, costs, and your business’s future.

In this episode

Chapters

Transcript

Auto-generated from the episode audio and lightly edited for readability.

0:07 For decades, the American cannabis industry has operated under a rather unusual contradiction. You can legally purchase cannabis in one state, drive across the border into another state where cannabis is also legal, and suddenly transporting that

0:25 very same product could put you in violation of federal law. Two legal markets separated by a state border and a federal regulatory system that has historically treated cannabis very differently from almost every other major consumer industry.

0:43 But something significant just happened. On October 30th, 2026, the Department of Justice announced that the DEA was moving forward with federal registrations for more than 900 medical cannabis dispensaries across seven states, Alabama, Florida, Mississippi,

1:02 South Dakota, Texas, Virginia, and West Virginia. And while that might sound like another administrative development, I think the implications deserve considerably more attention because for the first time under this new framework, we're

1:20 seeing hundreds of state licensed medical cannabis dispensaries receive federal registrations to operate within a regulated medical cannabis system. And that raises a much bigger question. Are we witnessing the beginning of a fundamentally different cannabis supply

1:38 chain? Now, before we start talking about interstate commerce, we need to understand what the DEA actually announced because there is a difference between a major regulatory development and the assumption that cannabis companies can suddenly start shipping products anywhere in the country.

1:57 Earlier this year in April, the federal government established a new framework placing certain qualifying medical marijuana activities under schedule 3 controls that created a pathway for state-licensed medical cannabis businesses to apply for federal

2:15 registration. And on October 30th, the DEA began issuing those registrations. More than 900 dispensaries were included in the initial phase while applications from additional dispensaries, manufacturers, and distributors continued through the review process.

2:35 And that distinction is important. We're not talking about the federal legalization of recreational cannabis. We're talking about qualifying medical cannabis activities operating within a specific federal regulatory framework. Businesses still have to meet federal

2:53 requirements, including security standards, uh, recordkeeping, inventory controls, and other obligations associated with handling controlled substances. And simply having a state cannabis license doesn't automatically mean a business has federal

3:11 authorization. But here's where things become particularly interesting. The regulatory framework also provides a pathway for qualifying manufacturers and distributors to operate under a federal registration. And under the applicable rules, registered businesses may be able to

3:29 transfer medical cannabis to other appropriately authorized businesses subject to their state licenses and federal requirements. Now, think about what that could eventually mean. For years, cannabis companies have built entire business models around their restrictions imposed by state borders. A company operating in

3:49 California can't simply assume it can supply a dispensary in New York. A distributor operating in one state can't automatically extend its distribution network into another. and brands looking to expand nationally have often needed to establish separate product arrangements,

4:08 licensing relationships, and operational infrastructure in each market. That's an extraordinarily complicated way to build a national industry. But it's also the environment cannabis businesses have been forced to navigate. And when you build an entire industry around those restrictions, something interesting

4:27 happens. The restrictions themselves begin shaping the business models where companies manufacture, where they invest, how they distribute products, who they partner with, and ultimately how much it costs to bring those products to consumers. So when the

4:45 federal government begins establishing a registration system that could, you know, support a more connected medical cannabis supply chain, the potential consequences go far beyond paperwork. But there's something we absolutely need to clarify. This announcement does not mean unrestricted interstate cannabis

5:05 commerce is now legal. State laws still matter. Federal registrations have defined limits and a business cannot simply ignore restrictions imposed by the states in which it operates. In other words, the federal government may be creating a pathway, but that

5:25 doesn't mean every state is ready or legally able to participate in the same way. And that's why I think the real story isn't necessarily that interstate commerce has arrived. It's that the regulatory foundations of the cannabis industry may be beginning to change. And that creates some fascinating questions.

5:45 If medical cannabis can eventually move more freely between states, what happens to businesses that have invested millions of dollars building separate facilities in multiple markets? What happens to smaller cultivators competing against producers in states with significantly lower production costs? And what happens to distributors whose

6:05 entire business models were designed around operating within a single state's borders? Because regulatory changes don't just create opportunities. They can also change the economics of businesses that were built under the previous rules. And that's what makes this announcement

6:23 worth examining. Not simply what the DEA has authorized today, but what a more connected cannabis industry could look like tomorrow. So let's look at the business implications because if state borders eventually become less important to the movement of medical cannabis, the way companies manufacture, distribute,

6:43 and compete could change dramatically. Now let's imagine that interstate medical cannabis commerce becomes a practical reality across much of the United States. What would that actually do to the economics of the cannabis industry? Because for years, state

7:01 borders haven't just been regulatory boundaries. They've determined where cannabis gets grown where it gets manufactured, distributed, and sold. And when you force an industry to operate within dozens of separate markets, you create some unusual business conditions.

7:19 A cannabis company looking to expand into five states might need separate production facilities, manufacturing partnerships, licenses, and distribution networks just to operate in those markets. And every one of those requirements comes with a cost. So what

7:38 happens if those barriers begin to disappear? Let's start with cultivation. Different states have very different production costs. electricity, labor, real estate, um, climate, and regulatory requirements all influence how much it costs to grow cannabis. If interstate commerce

7:56 expands, companies could increasingly concentrate production in locations where cultivation is more economical, let's say, and suddenly a cultivator operating in an expensive market might find itself competing against producers with significantly lower costs, which

8:14 raises an uncomfortable question. If your business depends on customer customers having limited access to products from outside your state, how competitive are you when those restrictions change? Now, for cannabis brands, the implications could be equally significant. Companies might

8:33 eventually consolidate production, improve consistency, and expand into new markets without recreating their entire infrastructure. But easier market access also means more competition. And having a recognizable brand might no longer be enough. Product quality, pricing,

8:51 reliability, and retailer relationships could become even more important. And then there's distribution. This is particularly interesting to me because I've spent a considerable part of my career working in cannabis distribution. And a distributor that previously served

9:10 one state could potentially expand into several. But that also means more complicated logistics, additional compliance requirements, and greater financial exposure. Reaching more customers doesn't automatically mean you're equipped to serve them profitably. And manufacturers might

9:30 reconsider where they need the same distribution partnerships they've historically relied on. But here's something we need to clarify. The DEA's announcement doesn't mean unrestricted interstate commerce is suddenly legal. Federal registration

9:49 requirements still apply. State laws still matter and qualifying businesses need to ensure they're working with appropriately authorized partners. So in the short term, this transition could actually make certain operations more complicated rather than simpler.

10:10 But now, what about retailers? Greater interstate access could eventually mean more suppliers, more product variety, and increased competition on wholesale pricing. But retailers would still need to manage inventory, evaluate margins, maintain supplier relationships, and

10:29 meet their financial obligations because more purchasing options doesn't automatically translate into better business decisions. And that's really the bigger picture here. For years, cannabis companies have competed within markets largely defined by regulations. But if those markets become more connected, competition could

10:48 increasingly depend on operational efficiency, production costs, product quality, and financial performance. Some businesses might discover enormous opportunities. Others might find their businesses were more dependent on regulatory barriers

11:07 than they realized. So, here's a question I leave cannabis operators with. If the restrictions that helped shape your business began to disappear, would your company become more competitive or would those changes expose its weaknesses? Because in the

11:25 final part of today's episode, we're going to examine exactly that. Who benefits? Who faces the greatest pressure? And whether the industry's biggest companies are necessarily the ones best positioned for what comes next. So, if interstate medical cannabis

11:43 commerce continues to develop, who actually stands to benefit? The obvious answer might be the industry's largest operators, companies with established infrastructure, access to capital, and operations across multiple states. But I'm not convinced that being the

12:03 biggest automatically means being the best positioned because size and efficiency are two very different things. A company operating in 10 states might have a significant market presence, but it could also be managing 10 different sets of expenses, facilities, even employees and

12:21 operational challenges. And if regulations eventually allow businesses to consolidate certain operations, that infrastructure could become an advantage or an expensive burden. Meanwhile, smaller operators might have something the larger companies struggle with.

12:40 Flexibility. A smaller manufacturer with excellent products, efficient production, and strong commercial relationships might suddenly have opportunities to reach customers that were previously inaccessible. But there's another side to that equation. Smaller businesses could also face competition from companies with

12:58 significantly greater resources, purchasing power, and distribution capabilities. And that's where I think we need to separate opportunity from reality. A larger addressable market doesn't automatically create a more profitable business. More customers can

13:16 mean more orders, but also more inventory, more operational expenses, and potentially more outstanding receivables. And this is something we deal with regularly at HQ because when businesses grow, the financial operations

13:35 supporting that growth become increasingly important. Accounts receivable management, payment collections, accurate accounting, inventory visibility, and efficient order processing aren't necessarily the most exciting parts of the cannabis industry, but they're often the difference between a company that's

13:53 growing sustainably and one that's simply getting bigger. Imagine a cannabis brand expanding its wholesale operations into several new markets. Its sales increase, its retailer network expands, and everything looks fantastic on paper. But what happens if those

14:11 retailers aren't paying on time? What happens when inventory is moving faster than the company can reconcile its transactions or when operational expenses increase faster than actual cash collections, revenue growth without financial discipline can become a very expensive

14:30 problem. And that's why I believe the companies that benefit most from the future regulatory changes won't necessarily be those with the largest facilities or the biggest marketing budgets. They'll be the companies capable of adapting quickly, controlling costs, and maintaining strong

14:49 operational and financial systems. Now, I also think we need to be realistic about the DEA announcement itself. We're still talking about a specific medical cannabis framework with federal registration requirements, state level restrictions, and significant compliance obligations. This isn't the

15:08 moment when every cannabis company can suddenly start shipping products nationwide. And we don't yet know how quickly or how extensively interstate medical cannabis commerce might develop. But that uncertainty is exactly why businesses should be paying attention because the

15:27 companies that wait until an industry has completely changed before adapting are often the ones left struggling to catch up. So whether you're a cultivator, a manufacturer, a distributor, or a retailer even, I'd encourage you to consider one question.

15:47 Is your business built to succeed because of the current regulatory environment or despite it? Because those are two very different foundations for long-term success. And at HQ, we help cannabis businesses strengthen the operational side of their companies from accounts receivable and

16:06 accounting support to order entry, inside sales, and data management. And if improving operational efficiency is part of your strategy heading into 2027, you can learn more at tryheadquarters.com. But ultimately, here's what I want you to take away from

16:24 today's episode. The DEA's announcement may not have eliminated state borders from the cannabis industry, but it has given us another reason to question how much longer those borders will define its future. And when that future arrives, the winners won't

16:42 necessarily be the companies that grew the fastest. They'll be the ones that built businesses capable of surviving when the rules of competition changed.